Administration of RAS Inhibitor before the Onset of Diabetic Nephropathy Counteracts the Adverse Effect of Chronic Hyperglycemia and Reduces the Augmentation of Urinary Albumin Excretion: A Retrospective Clinical Study

It is very important to explore how we can reduce urinary albumin excretion which is an independent risk factor for ischemic heart disease. In this study, we retrospectively evaluated the effects of RAS inhibitor therapy on diabetic nephropathy in Japanese subjects whose urinary albumin levels were...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:J Diabetes Res
Autors principals: Hirukawa, Hidenori, Kamei, Shinji, Kimura, Tomohiko, Obata, Atsushi, Kohara, Kenji, Tatsumi, Fuminori, Shimoda, Masashi, Nakanishi, Shuhei, Mune, Tomoatsu, Kaku, Kohei, Kaneto, Hideaki
Format: Artigo
Idioma:Inglês
Publicat: Hindawi 2018
Matèries:
Research Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6247477/
https://ncbi.nlm.nih.gov/pubmed/30525055
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2018/9435401
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars